Filing Flows › Neogen (NEOG) › Q1 FY27 › vs Q4 FY26
Neogen (NEOG) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Neogen's revenue fell $2.5M (-1%) from $225M in Q4 FY26 to $223M in Q1 FY27. The biggest changes: Product −$2.8M (-1%); Service +$300K (+1%).
Neogen, Q1 FY27: revenue $223M (+6% year over year), operating margin -0.8%, net loss $11.9M, operating cash flow $12.9M. The chart draws each line against Q4 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Product | $196M | $199M | −$2.8M | -1% |
| Service | $26.8M | $26.5M | $300K | +1% |
| Revenue | $223M | $225M | −$2.5M | -1% |
| Income tax benefit | $3.0M | $800K | $2.2M | +275% |
| Net loss | $11.9M | $11.3M | $600K | +5% |
| Costs & expenses | $238M | $237M | $300K | +0.1% |
| Operating costs | $225M | $222M | $2.4M | +1% |
| Interest & other, net | $13.1M | $15.2M | −$2.1M | -14% |
| Cost of revenue | $117M | $118M | −$200K | -0.2% |
| Research & development | $6.5M | $4.9M | $1.6M | +33% |
| Sales & marketing | $41.5M | $41.1M | $400K | +1% |
| General & admin | $59.3M | $58.7M | $600K | +1% |
| Operating cash sources | $32.2M | $32.4M | −$200K | -0.6% |
| Depreciation & amortization | $29.1M | $29.4M | −$300K | -1% |
| Share-based compensation | $3.1M | $3.0M | $100K | +3% |
| Net loss absorbed | $11.9M | $11.3M | $600K | +5% |
| Working capital & other | $7.4M | −$9.1M | $16.5M | — |
| Operating cash flow | $12.9M | $30.2M | −$17.3M | -57% |
Questions
How much did Neogen's revenue grow quarter over quarter in Q1 FY27?
Neogen's revenue fell $2.5M (-1%) from $225M in Q4 FY26 to $223M in Q1 FY27.
What drove Neogen's revenue change in Q1 FY27?
Product −$2.8M (-1%); Service +$300K (+1%).